The objective of this study was to examine, using the new WHO criteria for diabetes mellitus, whether insulin and glucose before and after an oral glucose tolerance test would predict cardiovascular mortality in hypertensive men with normal fasting blood glucose. A standard oral glucose challenge was performed after an overnight fast in 113 hypertensive men with either hypercholesterolaemia or smoking. These patients were recruited from an on-going risk factor intervention study. The mean observation time was 6.3 years. During follow-up there were 10 cardiovascular deaths. The Cox regression analyses showed an independent and significant association (P Ͻ 0.05) between blood glucose 120 min
Introduction
Diabetes mellitus is a well-known risk factor for cardiovascular mortality. 1, 2 There are also studies suggesting hyperinsulinaemia, but not hyperglycaemia as a major cardiovascular risk factor. 3, 4 However not all studies have found that hyperinsulinaemia is a cardiovascular risk factor. 5 Others have found that hyperglycaemia following oral glucose tolerance test predict coronary heart disease. 6 Thus, results from epidemiological studies in this research area are heterogeneous.
Most of the previous studies have been performed in healthy subjects, therefore data on hypertensive patients are sparse. This group of patients is especially important since the combination of hypertension and diabetes mellitus is deleterious. 1, 7 The growing knowledge about the close relationship between diabetes mellitus and cardiovascular morbidity and intervention studies showing that the poor prognosis in both type I and type II diabetes mellitus can be improved, 8, 9 has been the rationale after the glucose ingestion and cardiovascular death during follow-up. Fasting glucose, fasting insulin and insulin 120 min after glucose ingestion was not related to cardiovascular death during follow-up. In conclusion, this is the first study using the current definition of diabetes mellitus showing that hyperglycaemia following an oral glucose load is an independent risk factor for cardiovascular death in hypertensive men with a normal fasting glucose. In this type of hypertensive patient with normal fasting glucose, an oral glucose tolerance test may help to identify subjects at high cardiovascular risk.
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for the continuous changes of the WHO definition of diabetes mellitus. 10 We have performed a standard oral glucose tolerance test in a group of hypertensive men with normal blood glucose and these patients have been followed up for more than 6 years. Therefore we wanted to examine, using the new WHO criteria for diabetes mellitus 10 in a hypothesis seeking study, whether this test would predict cardiovascular mortality in this group of hypertensive men with normal fasting blood glucose values.
Subjects and methods

Subjects
Five hundred and eight male patients with treated primary hypertension were included in a risk factor intervention study. 7 The inclusion criteria for the intervention study were, apart from treated hypertension and male sex, one or more of the following: hypercholesterolaemia (serum cholesterol Ͼ6.5 mmol/L), tobacco smoking (one or more cigarettes per day) or diabetes mellitus. The patients were representative of high-risk hypertensives in Gothenburg since the majority (over 90%) were recruited by screening a random third of all men in their respective age groups. 11 In the intervention
Journal of Human Hypertension study, mentioned above, the patients had been randomised either to a multiple risk factor treatment programme or to conventional treatment. The intervention programme was based upon a non-pharmacological, and if necessary pharmacological regimen, aiming at lowering hypercholesterolaemia and also a smoking cessation programme. 7 From this group of 508 men one-third of the patients were randomly selected to take part in an ultrasound study of the carotid artery. 12 Out of these 164 patients an oral glucose tolerance test was performed in 121 non-diabetic subjects. The subjects with diabetes mellitus did not undergo the examination. Recently, the definition of diabetes mellitus was revised 10 and therefore it was subsequently decided to exclude eight subjects considered to be non-diabetic at inclusion with a fasting blood glucose between 6.1 and 6.7 mmol/l to make the results up-dated to the current definition of diabetes mellitus. Thus, 113 patients were included in the present study. All subjects gave informed consent after written and oral information and the ethical committee of the Faculty of Medicine, Gö teborg University, approved the study.
Measurements
Resting blood pressure was measured phonographically (Korotkoff sounds recorded on ECG paper) in the right arm after supine rest in connection with the ultrasound examination as previously described. 13 Body mass index was measured according to recommended principles. Smoking was assessed by a questionnaire. Manifest cardiovascular disease was defined as a history of cardiovascular disease (one or more of the following diagnoses: stroke, myocardial infarction, angina pectoris, intermittent claudication). Established criteria for stroke, myocardial infarction, angina pectoris and intermittent claudication were used. 7 Venous blood was drawn after an overnight fast and after 5 min of supine rest for determination of serum levels of triglycerides and cholesterol using established methods. 7 A standard oral glucose challenge was performed after an overnight fast. Before and following ingestion of 75 g glucose, blood was drawn for the determination of blood glucose and plasma insulin concentrations at −1, 30, 60 and 120 min, using glucose oxidase technique and a RIA assay (Pharmacia Insulin RIA, Pharmacia Diagnostics, Sweden), respectively.
Follow-up
No patient was lost to follow-up. Cardiovascular death was defined as any of the following diagnoses: fatal myocardial infarction, sudden death, fatal stroke, progressive cardiac failure, ruptured aortic aneurysm, or probably cardiovascular death (no other obvious cause of death). Two doctors who did not participate in the study and who had no knowledge of patient identity or of laboratory measurements independently coded all events. They had access to copies of hospital records, autopsy records and death certificates.
Statistical analysis
Results are presented as means ± s.d. Student's t-test was used to compare continuous variables. Categorical variables were analysed by Fischer's exact test. Relative risk and 95% confidence interval were calculated with the Cox regression model. Relative risk was calculated as the risk when the variable in focus was increased with one unit [(x+1)/x]. Only two-sided tests were performed and P Ͻ 0.05 was regarded as statistically significant.
Results
Baseline characteristics
Characteristics of the patients are shown in Table 1 . No patient was lost to follow-up. The mean duration of follow-up was 6.3 ± 1.3 years. During follow-up there were 10 cardiovascular deaths (seven myocardial infarctions/sudden coronary deaths, two strokes and one ruptured aortic aneurysm). When entry characteristics of the subjects who died of a cardiovascular disease during follow-up (n = 10) were compared with the entry characteristics of the other patients (n = 103), the former group had lower diastolic blood pressure (73 ± 11 and 82 ± 10, respectively, P Ͻ 0.05), a higher prevalence of concomitant cardiovascular disease (70% and 22%, respectively, P Ͻ 0.05) and a higher blood glucose 120 min after glucose ingestion during the oral glucose tolerance test (7.2 ± 1.7 and 5.9 ± 1.8, respectively, P Ͻ 0.05) compared with the latter group.
The median blood glucose 120 min after glucose ingestion during the oral glucose tolerance test was 5.9 mmol/l.
Among the 10 cardiovascular deaths, two subjects had a blood glucose 120 min after glucose ingestion below the median value and eight subjects were over the median value (P = 0.05). Forty-four subjects had blood glucose 120 min after glucose ingestion below 5.6 mmol/l. None of these 44 subjects had a cardiovascular death during follow-up.
Prediction of the risk of cardiovascular death
Cox regression analyses were initially performed separately for the variables in focus. The analyses showed significant associations (P Ͻ 0.05) between blood glucose 120 min after the glucose ingestion and cardiovascular death during follow-up (Table  2) . Fasting glucose, fasting insulin and insulin 120 min after glucose ingestion was not related to cardiovascular death during follow-up (Table 2) . Diastolic blood pressure and concomitant cardiovascular disease were also significantly associated with cardiovascular death during follow-up (P Ͻ 0.05). When subjects with concomitant cardiovascular disease were excluded, the diastolic blood pressure level did nor predict cardiovascular mortality. When all variables, associated (P Ͻ 0.1) with cardiovascular death during follow-up (diastolic blood pressure, triglycerides, blood glucose 120 min after the glucose ingestion, smoking, group belonging, concomitant cardiovascular disease) were included in a Cox regression analysis blood glucose at 120 min during the oral glucose remained significantly associated with future cardiovascular death (relative risk 1.56, 95% confidence interval 1.03-2.48, P = 0.03) ( Table 3) .
Discussion
This is the first study, using the new WHO criteria for diabetes mellitus, 10 demonstrating that blood glucose 120 min after glucose ingestion was an independent predictor for cardiovascular death during follow-up in hypertensive men with normal fasting blood glucose.
Thirty-nine per cent of the subjects had blood glucose 120 min after glucose ingestion below 5.6 mmol/l. None of these 44 subjects had a cardiovascular death during follow-up, whereas there were 10 cardiovascular deaths among the 69 patients with blood glucose 120 min after glucose ingestion above 5.6 mmol/l. Fasting glucose, fasting insulin and insulin 120 min after glucose ingestion was not related to cardiovascular death during follow-up.
The underlying mechanism behind the relationship between hyperglycaemia following an oral glucose tolerance test and cardiovascular mortality is not known. Hyperglycaemia may give rise to an endothelial injury. An impaired endothelial function has been demonstrated in subjects with insulindependent diabetes mellitus with poor metabolic control.
14 It is also well known that subjects with diabetes or impaired glucose tolerance often have other cardiovascular risk factors, such as hypertriglyceridaemia, hypertension and obesity. However, in the present study the hyperglycaemia following the glucose tolerance test was an independent predictor of cardiovascular mortality. Hyperglycaemia causes an increased non-enzymatic glycation of different proteins and lipoproteins, which leads to the formation and accumulation of advanced glycation end products 15 with a permanently altered function of cells, vessel walls and extracellular matrix. These changes might accelerate the atherosclerotic process.
Our observation of hyperglycaemia following a glucose load being a predictor of cardiovascular death was in line with previous studies of different populations using older definitions of diabetes mellitus. 6, 16 We found no association between either fasting insulin or insulin levels following a glucose load and cardiovascular mortality. Other groups have suggested such an association. In the Helsinki Policemen study post-load insulin levels were independent risk factors for coronary heart disease, jects aged 43-54 years, an increased level of fasting insulin was associated with an increased risk of coronary disease independent of other risk factors. 4 Thus, the subjects in these studies were much younger than our study group in which the mean age of the subjects was 66 years. Furthermore, another population-based study with the mean age of 67 years, also failed to recognise fasting or plasma insulin following a glucose load as cardiovascular risk factors. 5 An elevated insulin value may well be an important cardiovascular risk factor in middle-aged subjects and those who are susceptible may die before reaching the age of the present study population. Another difference between our study and the previous population-based studies is the high prevalence of other cardiovascular risk factors among the subjects in this study. All patients were hypertensive and they also had another cardiovascular risk factor and 30% of them had concomitant cardiovascular disease.
A low diastolic blood pressure was associated with an increased risk for cardiovascular death. This relationship has previously been reported 17, 18 and it is likely that the low diastolic blood pressure in these and the present study was a secondary phenomenon to a concomitant vessel disease. Thus, when subjects with concomitant cardiovascular disease at study entry were excluded from the analysis, a low diastolic blood pressure did not predict cardiovascular death.
In conclusion, this is the first study using the current definition of diabetes mellitus showing that hyperglycaemia following an oral glucose load is an independent risk factor for cardiovascular death in hypertensive men with a normal fasting glucose. In this type of hypertensive patient with normal fasting glucose, an oral glucose tolerance test may help to identify subjects at high cardiovascular risk.
